Barclays’s Monte Rosa Therapeutics GLUE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | $2.13M | Buy |
|
|||||
|
2025
Q3 | $541K | Sell |
|
|||||
|
2025
Q2 | $387K | Buy |
|
|||||
|
2025
Q1 | $214K | Sell |
|
|||||
|
2024
Q4 | $491K | Buy |
|
|||||
|
2024
Q3 | $289K | Buy |
|
|||||
|
2024
Q2 | $41.2K | Sell |
|
|||||
|
2024
Q1 | $153K | Sell |
|
|||||
|
2023
Q4 | $346K | Buy |
|
|||||
|
2023
Q3 | $63.1K | Sell |
|
|||||
|
2023
Q2 | $93.4K | Sell |
|
|||||
|
2023
Q1 | $118K | Buy |
|
|||||
|
2022
Q4 | $60.8K | Buy |
|
|||||
|
2022
Q3 | $10K | Sell |
|
|||||
|
2022
Q2 | $14K | Sell |
|
|||||
|
2022
Q1 | $128K | Buy |
|